Zhongbo Li
-
- Hippo pathway signaling and YAP/TAZ 7
-
- Cancer-related Molecular Pathways 4
- Cytokine Signaling Pathways and Interactions 3
-
- Ubiquitin and proteasome pathways 8
- Wnt/β-catenin signaling in development and cancer 2
-
- interferon and immune responses 2
-
- Anorectal Disease Treatments and Outcomes 2
- Colorectal and Anal Carcinomas 2
- Co-authors
- Huijie YangTing ZhuangJian ZhuPeng SuXin LiYinlu DingDanni HuangDehai Wang
- Journals
- Medicine (3 papers)Journal of Experimental & Clinical Cancer Research (3 papers)Cell Death and Disease (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Zhongbo Li
21 papers receiving 400 citations
Peers
Comparison fields: 5 of 74
- Cell Biology 77
- Oncology 116
- Molecular Biology 258
- Cancer Research 44
- Immunology 57
Countries citing papers authored by Zhongbo Li
This map shows the geographic impact of Zhongbo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongbo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongbo Li more than expected).
Fields of papers citing papers by Zhongbo Li
This network shows the impact of papers produced by Zhongbo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongbo Li. The network helps show where Zhongbo Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhongbo Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 14 | |
| 4 | 2024 | 11 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 12 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 17 | |
| 10 | 2023 | 14 | |
| 11 | 2023 | 22 | |
| 12 | 2023 | 4 | |
| 13 | 2022 | 17 | |
| 14 | 2022 | 11 | |
| 15 | 2022 | 9 | |
| 16 | 2022 | 45 | |
| 17 | 2022 | 18 | |
| 18 | 2020 | 81 | |
| 19 | 2019 | 74 | |
| 20 | 2010 | 31 |
About Zhongbo Li
Zhongbo Li is a scholar working on Cell Biology, Oncology and Immunology, having authored 22 papers that have together received 402 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (8 papers), Hippo pathway signaling and YAP/TAZ (7 papers), Cancer-related Molecular Pathways (4 papers), Cytokine Signaling Pathways and Interactions (3 papers), interferon and immune responses (2 papers), Anorectal Disease Treatments and Outcomes (2 papers), Colorectal and Anal Carcinomas (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Cell Biology (77 citations), Oncology (116 citations) and Molecular Biology (258 citations). Zhongbo Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Huijie Yang, Ting Zhuang, Jian Zhu, Peng Su, Xin Li, Yinlu Ding, Danni Huang, Dehai Wang, Chunhui Deng and Min Xue. Their work appears in journals such as Medicine, Journal of Experimental & Clinical Cancer Research, Cell Death and Disease, Oncogene and iScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.